


Disruptive Pharma Revenue
Pharmaceutical Manufacturing • Stockholm, Stockholm County, Sweden • 11-20 Employees
Disruptive Pharma revenue & valuation
| Annual revenue | $1,197,770 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $3,900,000 |
| Total funding | No funding |
Key Contacts at Disruptive Pharma
Peter Åsberg
Ceo
Martina Ferneman
Commercial Director
Company overview
| Headquarters | Nanna Svartz väg 4, Stockholm, Stockholm County 171 65, SE |
| Phone number | +46709491721 |
| Website | |
| NAICS | 3254 |
| Keywords | Product Development, Pharmaceuticals, Formulation, Bioavailability, Drug Delivery, Drug Formulation |
| Founded | 2021 |
| Employees | 11-20 |
| Socials |
Disruptive Pharma Email Formats
Disruptive Pharma uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@disruptivepharma.com), used 70% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@disruptivepharma.com | 70% |
{first initial}.{last name} | j.doe@disruptivepharma.com | 30% |
About Disruptive Pharma
Disruptive Pharma is an innovative clinical stage biotech and drug delivery company leveraging innovative its mesoporous magnesium carbonate (MMC) technology to enable amorphous drug formulations. Our cutting-edge MMC technology enables the transformation of pharmaceutical assets — APIs, NCEs, or development opportunities — into differentiated, commercially attractive drug products. With the recent advancement of our first product candidate into the clinical stage, we are now entering the scale-up phase, further demonstrating the potential of MMC in real-world drug development. The MMC technology produces stable amorphous formulations with optimal drug product characteristics, making it attractive solution for differentiation, for enablement of novel drugs and in lifecycle management strategies. An MMC amorphous drug simplifies development and optimizes product characteristics. Disruptive Pharma are seeking corporate relationships with biotech and pharmaceutical companies to create additional value across our product portfolio, pre-clinical candidates and MMC technology offerings.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Disruptive Pharma has 4 employees across 3 departments.
Departments
Number of employees
Funding Data
Disruptive Pharma has never raised funding before.
Frequently asked questions
4.8
40,000 users



